About Aquestive Therapeutics Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://aquestive.com/
Frequently Asked Questions
What is the 52-week range for AQST?
The 52-week high is $7.55 and the 52-week low is $2.93.
What is the P/E ratio for AQST?
The P/E ratio data is currently unavailable.
What is the dividend yield for AQST?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -21.76%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -144.63%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 15.59.
Analyst Recommendation Trends
Wall Street analyst consensus for AQST over the last few months:
Latest AQST News
Aquestive Therapeutics: The Market Is Already Pricing In Anaphylam's Success
Aquestive Therapeutics offers a differentiated epinephrine product, Anaphylm, but faces pricing and market share headwinds. Learn why AQST stock is a hold.
Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly
Appoints Rich Daly, a life sciences executive with more than 30 years of leadership experience across large pharmaceutical companies, emerging biotechnology companies, and public company boards, to its Board of Directors WARREN, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, toda
Aquestive Therapeutics Resubmits FDA Application for Pocket-Sized Allergy Treatment
Aquestive Therapeutics has resubmitted its New Drug Application to the FDA for Anaphylm, a sublingual film for severe allergic reactions.
Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
Resubmission supported by positive topline human factors and pharmacokinetic (PK) study results announced in August 2026FDA will determine the resubmission classification and establish the applicable review timeline following its initial review of the resubmission WARREN, N.J., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innova
Aquestive Therapeutics (AQST): Second Chance At Anaphylm Comes Into Focus
On August 11, Aquestive Therapeutics (NASDAQ:AQST) reported second-quarter 2026 results and said it remains on track to resubmit its Anaphylm epinephrine film to the FDA in the third quarter of 2026. That single sentence carries the whole story here. A company living and dying by one product candidate just cleared the studies standing between it […]
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-15 | Barber Daniel | -25,000 | $4.8195 | $120,487 |
| 2026-09-09 | Korczynski Sherry | -8,750 | - | - |
| 2026-09-09 | Korczynski Sherry | -8,750 | $5.22 | $45,675 |
| 2026-09-09 | Korczynski Sherry | +8,750 | $2.65 | $23,188 |
| 2026-09-09 | Boyd Peter E. | -2,293 | - | - |
| 2026-09-09 | Boyd Peter E. | +2,293 | $0.96 | $2,201 |
| 2026-09-08 | Barber Daniel | -91,743 | - | - |
| 2026-09-08 | Barber Daniel | +91,743 | $0.96 | $88,073 |
| 2026-09-03 | Jung Cassie | -4,587 | - | - |
| 2026-09-03 | Jung Cassie | +4,587 | $0.96 | $4,404 |
| 2026-08-17 | Barber Daniel | -25,000 | $4.2867 | $107,168 |
| 2026-08-14 | Korczynski Sherry | -2,714 | $4.25 | $11,535 |
| 2026-07-16 | Barber Daniel | -20,369 | $4.0016 | $81,509 |
| 2026-07-15 | Barber Daniel | -4,631 | $4.0344 | $18,683 |
| 2026-06-23 | Krop Julie | -25,000 | - | - |
| 2026-06-23 | Krop Julie | -25,000 | $5.0157 | $125,393 |
| 2026-06-23 | Krop Julie | +25,000 | $0.7132 | $17,830 |
| 2026-06-15 | Barber Daniel | -25,000 | $4.1604 | $104,010 |
| 2026-06-10 | Krop Julie | +50,500 | - | - |
| 2026-06-10 | Jenkins Abigail L. | -50,500 | - | - |
| 2026-06-10 | Cochran John | +50,500 | - | - |
| 2026-06-10 | Taglietti Marco | +50,500 | - | - |
| 2026-06-10 | BROWN GREGORY B | +50,500 | - | - |
| 2026-06-10 | MORRIS TIMOTHY E | +50,500 | - | - |
| 2026-06-08 | Korczynski Sherry | -2,714 | - | - |
| 2026-05-18 | Zalewski Thomas A. | +75,000 | - | - |
| 2026-05-18 | Zalewski Thomas A. | +100,000 | - | - |
| 2026-05-15 | Barber Daniel | -8,257 | $4.2889 | $35,413 |
| 2026-05-15 | Cioffi Melina | -1,667 | $4.17 | $6,951 |
| 2026-05-07 | BRAENDER LORI J | -135,690 | $4.23 | $573,969 |
| 2026-05-05 | Boyd Peter E. | -56,778 | $4.18 | $237,332 |
| 2026-05-05 | Barber Daniel | -335,922 | $4.18 | $1,404,154 |
| 2026-05-05 | Jung Cassie | -72,734 | $4.18 | $304,028 |
| 2026-05-05 | BRAENDER LORI J | -76,147 | $4.18 | $318,294 |
| 2026-05-05 | TOTH A ERNEST JR | -92,652 | $4.18 | $387,285 |
| 2026-03-10 | Boyd Peter E. | -29,814 | $4.173 | $124,414 |
| 2026-03-10 | Barber Daniel | -180,677 | $4.173 | $753,965 |
| 2026-03-10 | BRAENDER LORI J | -40,102 | $4.173 | $167,346 |
| 2026-03-10 | Cioffi Melina | -25,311 | $4.173 | $105,623 |
| 2026-03-10 | Korczynski Sherry | -15,741 | $4.173 | $65,687 |
| 2026-03-10 | Jung Cassie | -45,791 | $4.173 | $191,086 |
| 2026-03-10 | TOTH A ERNEST JR | -58,254 | $4.173 | $243,094 |
| 2026-03-09 | Boyd Peter E. | +42,500 | $4.29 | $182,325 |
| 2026-03-09 | Boyd Peter E. | +80,000 | - | - |
| 2026-03-09 | Barber Daniel | +523,000 | $4.29 | $2,243,670 |
| 2026-03-09 | Barber Daniel | +262,000 | - | - |
| 2026-03-09 | BRAENDER LORI J | +50,000 | $4.29 | $214,500 |
| 2026-03-09 | BRAENDER LORI J | +80,000 | - | - |
| 2026-03-09 | Cioffi Melina | +75,000 | $4.29 | $321,750 |
| 2026-03-09 | Cioffi Melina | +100,000 | - | - |
| 2026-03-09 | Korczynski Sherry | +42,500 | $4.29 | $182,325 |
| 2026-03-09 | Korczynski Sherry | +75,000 | - | - |
| 2026-03-09 | Jung Cassie | +42,500 | - | - |
| 2026-03-09 | Jung Cassie | +80,000 | - | - |
| 2026-03-09 | Davis Matthew W. | +50,000 | - | - |
| 2026-03-09 | Davis Matthew W. | +50,000 | - | - |
| 2026-03-09 | Greenhawt Matthew J. | +50,000 | $4.29 | $214,500 |
| 2026-03-09 | Greenhawt Matthew J. | +75,000 | - | - |
| 2026-03-09 | TOTH A ERNEST JR | +70,000 | - | - |
| 2026-03-09 | TOTH A ERNEST JR | +95,000 | - | - |
| 2025-12-04 | Boyd Peter E. | +20,000 | - | - |
| 2025-12-02 | Cioffi Melina | -2,083 | $5.93 | $12,352 |
| 2025-11-10 | Davis Matthew W. | +50,000 | - | - |
| 2025-11-10 | Davis Matthew W. | +50,000 | - | - |
| 2025-10-15 | Jung Cassie | -25,000 | - | - |
| 2025-10-15 | Jung Cassie | -67,575 | $7.01 | $473,701 |
| 2025-10-15 | Jung Cassie | +25,000 | $3.1027 | $77,568 |
| 2025-10-15 | Kraus Carl N | -20,272 | $7 | $141,904 |
| 2025-10-15 | Boyd Peter E. | -10,000 | $7 | $70,000 |